Anileridine

This classification denotes an opioid receptor agonist and opioid with the molecular formula C22H28N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 71Q1A3O279, chemically known as 4-piperidinecarboxylic acid, 1-(2-(4-aminophenyl)ethyl)-4-phenyl-, ethyl ester but generally known as anileridine, which bears US NIH Compound Identifier 8944. Anileridine most often comes in base, dihydrochloride, and hydrochloride forms. European Medicines Agency schedules Anileridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05514MIG. The term ANILERIDINE is an International Non-Proprietary Name. World Health Organization schedules anileridine in its Anatomical Therapeutic Chemical (ATC) Classification. ANILERIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule anileridine under HS 29333300 and SITC 51574. As of Q4 2014, ANILERIDINE remains the US FDA Preferred Term for this commodity. Anileridine bears US NLM identifiers UMLS ID C0051908 and NCI Concept Code C65234. SMILES: O(C(=O)C1(CCN(CC1)CCC1CCC(N)CC1)C1CCCCC1)CC.